Clinical Laserthermia Systems AB (publ) announced that its acting CEO Dan J. Mogren will go on a planned sick leave on Feb. 10, 2022 until the March 31, 2022. The Board of Directors has appointed Lars-Erik Eriksson, the company CFO and previous CEO, deputy CEO during this period.
Clinical Laserthermia Systems AB
Equities
CLS B
SE0022049920
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.048 SEK | +1.99% | -4.08% | -78.09% |
05-31 | Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue | MT |
05-29 | Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.09% | 4.51M | |
-3.23% | 808M | |
-30.61% | 219M | |
-31.50% | 78.95M | |
+15.84% | 61.92M |
- Stock Market
- Equities
- CLS B Stock
- News Clinical Laserthermia Systems AB
- Clinical Laserthermia Systems AB Announces CEO Changes